Cellectar Biosciences, Inc. (38)
Browse by Contract Category
Contracts
-
Form of Indemnification Agreement
(Filed With SEC on December 2, 2022)
-
Form of Registration Rights Agreement, dated as of October 20, 2022, by and between the Company and the purchasers named therein
(Filed With SEC on October 25, 2022)
-
Amendment 1 to the 2021 Stock Incentive Plan
(Filed With SEC on June 27, 2022)
-
Description of Securities Registered under Section 12(b) of the Securities Exchange Act of 1934
(Filed With SEC on May 10, 2022)
-
Form of PIPE Securities Purchase Agreement, dated as of October 20, 2022, by and between the Company and the purchasers named therein
(Filed With SEC on October 25, 2022)
-
Form of Hybrid Securities Purchase Agreement, dated as of October 20, 2022, by and between the Company and the purchasers named therein
(Filed With SEC on October 25, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on October 25, 2022)
-
Form of Common Warrant
(Filed With SEC on October 25, 2022)
-
Placement Agency Agreement, dated as of October 20, 2022, by and between Cellectar Biosciences, Inc. and Oppenheimer & Co. Inc
(Filed With SEC on October 25, 2022)
-
Employment Agreement between the Company and Chad Kolean, dated February 23, 2022
(Filed With SEC on February 25, 2022)
-
2021 Stock Incentive Plan
(Filed With SEC on June 24, 2021)
-
Description of Securities Registered under Section 12(b) of the Securities Exchange Act of 1934
(Filed With SEC on March 2, 2021)
-
Form of Registration Rights Agreement
(Filed With SEC on December 28, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on December 28, 2020)
-
Form of Series D Preferred Stock Certificate
(Filed With SEC on December 28, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on December 28, 2020)
-
Equity Distribution Agreement between Cellectar Biosciences, Inc. and Oppenheimer & Co. Inc., dated August 11, 2020
(Filed With SEC on August 11, 2020)
-
Employment Agreement between the Company and John Friend dated July 1, 2020
(Filed With SEC on July 1, 2020)
-
Amended and Restated 2015 Stock Incentive Plan
(Filed With SEC on June 25, 2020)
-
Form of Warrant Agency Agreement
(Filed With SEC on June 5, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on May 20, 2020)
-
Form of Series H Warrant
(Filed With SEC on May 20, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on May 20, 2020)
-
Stock Option Agreement with Igor Grachev
(Filed With SEC on March 9, 2020)
-
Stock Option Agreement with Dov Elefant
(Filed With SEC on March 9, 2020)
-
Description of Securities Registered under Section 12(b) of the Securities Exchange Act of 1934
(Filed With SEC on March 9, 2020)
-
Employment Agreement between the Company and Igor Grachev dated January 6, 2020
(Filed With SEC on January 7, 2020)
-
Amendment to Amended and Restated Employment Agreement between the Company and Jarrod Longcor, dated November 10, 2019
(Filed With SEC on November 12, 2019)
-
Employment Agreement between the Company and Dov Elefant dated August 15, 2019
(Filed With SEC on August 15, 2019)
-
Amended and Restated 2015 Stock Incentive Plan
(Filed With SEC on June 14, 2019)
-
Placement Agency Agreement dated as of May 16, 2019, by and between Cellectar Biosciences, Inc. and Roth Capital Partners, LLC
(Filed With SEC on May 20, 2019)
-
Registration Rights Agreement, dated as of May 16, 2019, by and among Cellectar Biosciences, Inc. and the Purchasers
(Filed With SEC on May 20, 2019)
-
Private Placement Securities Purchase Agreement, dated as of May 16, 2019, by and among Cellectar Biosciences, Inc. and the Purchasers
(Filed With SEC on May 20, 2019)
-
Securities Purchase Agreement, dated as of May 16, 2019, by and among Cellectar Biosciences, Inc. and the Purchasers
(Filed With SEC on May 20, 2019)
-
Form of Series G Common Stock Purchase Warrant
(Filed With SEC on May 20, 2019)
-
Form of Series F Common Stock Purchase Warrant
(Filed With SEC on May 20, 2019)
-
Amended and Restated Employment Agreement between the Company and Jarrod Longcor, dated April 15, 2019
(Filed With SEC on April 19, 2019)
-
Amended and Restated Employment Agreement between the Company and James Caruso, dated April 15, 2019
(Filed With SEC on April 19, 2019)
